Australia markets closed

Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
21.55-0.10 (-0.46%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 3.46B
Enterprise value 3.00B
Trailing P/E 16.18
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.54
Price/book (mrq)2.15
Enterprise value/revenue 1.36
Enterprise value/EBITDA 12.62

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-42.42%
S&P500 52-week change 322.64%
52-week high 344.66
52-week low 316.49
50-day moving average 321.00
200-day moving average 326.26

Share statistics

Avg vol (3-month) 31.99M
Avg vol (10-day) 32.47M
Shares outstanding 5159.64M
Implied shares outstanding 6159.64M
Float 866.32M
% held by insiders 164.52%
% held by institutions 15.05%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.5
Forward annual dividend yield 42.31%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 437.36%
Dividend date 3N/A
Ex-dividend date 424 May 2023
Last split factor 21.3:1
Last split date 324 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 11.92%
Operating margin (ttm)20.26%

Management effectiveness

Return on assets (ttm)6.39%
Return on equity (ttm)13.95%

Income statement

Revenue (ttm)1.9B
Revenue per share (ttm)11.91
Quarterly revenue growth (yoy)-45.10%
Gross profit (ttm)N/A
EBITDA 271.19M
Net income avi to common (ttm)226.67M
Diluted EPS (ttm)1.34
Quarterly earnings growth (yoy)42.90%

Balance sheet

Total cash (mrq)564.45M
Total cash per share (mrq)3.38
Total debt (mrq)38.39M
Total debt/equity (mrq)2.05%
Current ratio (mrq)2.12
Book value per share (mrq)10.10

Cash flow statement

Operating cash flow (ttm)203.67M
Levered free cash flow (ttm)145.73M